ENZY

Enzymotec Ltd
ENZY

Overview Fund Activity
Delisted

ENZY was delisted on the 10th of January, 2018.

Back to rankings

34 hedge funds and large institutions have $67.3M invested in Enzymotec Ltd in 2016 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
+4
Holders Change %
+13.33%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
14
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
GS
Gagnon Securities
New York
+$2.02M
2
Goldman Sachs
Goldman Sachs
New York
+$1.68M
3
GA
Gagnon Advisors
New York
+$1.59M
4
LCM
Laurion Capital Management
New York
+$1.57M
5
JHIU
Janus Henderson Investors US
Colorado
+$919K

Top Sellers

1
VAM
Visium Asset Management
New York
-$19.9M
2
TM
Tiger Management
New York
-$4.73M
3
Morgan Stanley
Morgan Stanley
New York
-$359K
4
GCP
GSA Capital Partners
United Kingdom
-$332K
5
Millennium Management
Millennium Management
New York
-$73.9K
Name Holding Trade Value Shares
Change 		Shares
Change %
Geode Capital Management
26
Geode Capital Management
Massachusetts
$84K -$20.7K -2,500 -20%
AIM
27
Acrospire Investment Management
Illinois
$80K +$56.6K +6,726 +242%
CLOS
28
Compagnie Lombard Odier SCmA
Switzerland
$33K – – –
JPMorgan Chase & Co
29
JPMorgan Chase & Co
New York
$30K +$30K +3,560 New
Walleye Trading
30
Walleye Trading
New York
$23K +$23K +2,700 New
PCM
31
Penserra Capital Management
California
$22K +$4.73K +564 +27%
UBS Group
32
UBS Group
Switzerland
$8K +$4.93K +598 +161%
Bank of America
33
Bank of America
North Carolina
$3K – – –
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$3K – – –
VAM
35
Visium Asset Management
New York
– -$19.9M -2,200,000 Closed
AIG
36
American International Group
New York
– -$7K -800 Closed
1
2